Opted out of 360Dx Molecular Diagnostics Bulletin

International Consensus Statement Says Microbiome-Based Diagnostic Tests Not Ready for Prime Time

Updated NCCN Guidelines Adjust Ratings for Prostate Cancer Genetic Tests

In Brief This Week: Myriad Genetics, Thermo Fisher Scientific, DeepUll, Roche, Immunovia, More

Cepheid Tuberculosis Assay Receives WHO Prequalification

VA Offering No-Cost PGx Testing Through End of 2025

GeneDx Launches Program to Boost Access to Exome Testing for Pediatric Epilepsy Patients